How have PHMMF shares performed in 2024?

Pharma Mar's stock was trading at $46.26 at the start of the year. Since then, PHMMF shares have decreased by 36.7% and is now trading at $29.29. View the best growth stocks for 2024 here .

How do I buy shares of Pharma Mar?

Shares of PHMMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:PHMMF

Pharma Mar (PHMMF) Stock Price, News & Analysis

→ Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad)

Free PHMMF Stock Alerts

$29.29

0.00 (0.00%)

(As of 04/15/2024 ET)

Compare

Today's Range: $29.29
▼
$29.29
50-Day Range: $26.85
▼
$44.13
52-Week Range: $26.85
▼
$46.26

Volume: 24 shs
Average Volume: 9 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Headlines Short Interest

Get Pharma Mar alerts:

Ad InvestorPlace

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

Click here to see the details because there’s a lot of money at stake.

About Pharma Mar Stock (OTCMKTS:PHMMF)

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, France, rest of EU, the United States, and internationally. The company operates through Oncology and RNA interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14, which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trial for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trial for treating solid tumors; Tivanisiran, which is in Phase III clinical trial for the treatment of dry eye disease; and SYL1801 that is in phase II clinical trial for treating macular degeneration. In addition, it engages in the development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. The company was incorporated in 1986 and is based in Madrid, Spain.

PHMMF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PHMMF Stock News Headlines

March 18, 2024 | markets.businessinsider.com

Pharming Group’s Strong Performance and Growth Prospects Justify Buy Rating

March 16, 2024 | newsweek.com

Mar-a-lago

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

March 7, 2024 | markets.businessinsider.com

Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain

February 17, 2024 | investing.com

Pharma Mar SAU (PHMR)

February 1, 2024 | investorplace.com

Pfizer’s 2024 Comeback: A Dividend Gem in the Pharma Market

January 9, 2024 | msn.com

Two new databases combine computer science and pharmaceutical research

November 29, 2023 | msn.com

First West Africa Healthcare, Lab, & Pharma Week 2024 To Hold In Nigeria

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

November 6, 2023 | morningstar.com

Pharma Mar SA PHM

October 28, 2023 | markets.businessinsider.com

Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024

July 15, 2023 | barrons.com

Pharma Mar S.A.

June 21, 2023 | forbes.com

Yifan Pharmaceutical

June 6, 2023 | finance.yahoo.com

PHM.MC - Pharma Mar, S.A.

April 22, 2023 | msn.com

NEEDHAM & COMPANY INC. Maintains Pharma Mar (XMAD:PHM) Buy Recommendation

March 27, 2023 | marketwatch.com

Pharmaceutical Excipients Market Top Players By 2031

March 25, 2023 | news.yahoo.com

Pharmaceutical company to open in McHenry

March 24, 2023 | markets.businessinsider.com

Innate Pharma (IPHA) Receives a Buy from H.C. Wainwright

March 16, 2023 | bizjournals.com

Big Pharma companies back new startup out of Mass General Brigham

November 9, 2022 | markets.businessinsider.com

Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023

October 10, 2022 | yahoo.com

European Commission suspects pharma group Teva broke antitrust rules

August 30, 2022 | apnews.com

Pharmacists Database List of Emails, Phone Numbers, Contact Information

January 11, 2022 | finance.yahoo.com

Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants

November 11, 2021 | finanznachrichten.de

PharmaMar signs a licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in Taiwan

October 28, 2021 | news.yahoo.com

Spain's PharmaMar posts 58% drop in 9-mth profit despite higher revenues

October 28, 2021 | reuters.com

Spain's PharmaMar nine-month net profit falls 58%

July 29, 2021 | nasdaq.com

Spain's PharmaMar sales rise on demand for cancer treatments

See More Headlines

Receive PHMMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma Mar and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Private households
Sub-Industry: N/A
Current Symbol: OTCMKTS:PHMMF
Previous Symbol: NASDAQ:PHMMF
CUSIP: N/A
CIK: N/A
Web: www.pharmamar.com
Phone: (491) 846-6000
Fax: 34-91-846-6001
Employees: 509
Year Founded: 1986

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.13
Current Ratio: 3.01
Quick Ratio: 2.61

Sales & Book Value

Annual Sales: $171.15 million
Price / Sales: N/A
Cash Flow: $3.23 per share
Price / Cash Flow: 9.06
Book Value: $13.04 per share
Price / Book: 2.25

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.20

Social Links

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Jose Maria Fernandez Sousa-Faro Ph.D.
Founder, Executive Chairman, CEO & President
Mr. Pedro Francisco Fernandez Puentes
Executive Director
Mr. Juan Carlos-Torres Carretero (Age 75)
Founder
Ms. María Luisa de Francia Caballero
Chief Financial Officer
Mr. José Luis Moreno Martinez-Losa
Director of Capital Markets & Investor Relations
Mr. Juan Gomez Pulido
General Counsel & Secretary of the Board of Directors
Ms. Sandra Llamera Sanchez
Global Compliance Head
Ms. Lara Vadillo
Communication Director
Ms. Belén Sopesén Veramendi Ph.D.
Director of Corporate Development
Mr. Luis Rupérez Cuenca
Director of Human Resources & IT

Key Competitors

View All Competitors

PHMMF Stock Analysis - Frequently Asked Questions

How have PHMMF shares performed in 2024?: Pharma Mar's stock was trading at $46.26 at the start of the year. Since then, PHMMF shares have decreased by 36.7% and is now trading at $29.29.
View the best growth stocks for 2024 here.
How do I buy shares of Pharma Mar?: Shares of PHMMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PHMMF) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Pharma Mar (PHMMF) Stock Price, News & Analysis

About Pharma Mar Stock (OTCMKTS:PHMMF)

PHMMF Stock Price History

PHMMF Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

PHMMF Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info